British Journal of Haematology

Multiple myeloma with unusual inclusions
pp. 1-1(1)
Authors: Frotscher, Birgit; Salignac, Sylvain; Lecompte, Thomas

Mycobacterium kansasii in a patient with hairy cell leukaemia
pp. 2-2(1)
Authors: Green, Laura; Coumbe, Adam; Sawicka, Elizabeth; De Lord, Corinne

Large-scale blood group genotyping - clinical implications
pp. 3-13(11)
Author: Avent, Neil D.

An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products
pp. 14-23(10)
Authors: Turner, Marc L.; Ludlam, Christopher A.

Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science
pp. 24-40(17)
Authors: Hochberg, Jessica; Waxman, Ian M.; Kelly, Kara M.; Morris, Erin; Cairo, Mitchell S.

Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells
pp. 41-52(12)
Authors: Bouzar, Amel Baya; Boxus, Mathieu; Defoiche, Julien; Berchem, Guy; Macallan, Derek; Pettengell, Ruth; Willis, Fenella; Burny, Arsène; Lagneaux, Laurence; Bron, Dominique; Chatelain, Bernard; Chatelain, Christian; Willems, Luc

Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators
pp. 53-68(16)
Authors: Hatfield, Kimberley; Øyan, Anne M.; Ersvaer, Elisabeth; Kalland, Karl-Henning; Lassalle, Philippe; Gjertsen, Bjørn T.; Bruserud, Øystein

Dysregulation of stromal derived factor 1/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia
pp. 69-77(9)
Authors: Salim, Juan P.; Goette, Nora P.; Lev, Paola R.; Chazarreta, Carlos D.; Heller, Paula G.; Alvarez, Clarisa; Molinas, Felisa C.; Marta, Rosana F.

Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia
pp. 78-85(8)
Authors: Karlsson, Claes; Lundin, Jeanette; Kimby, Eva; Kennedy, Ben; Moreton, Paul; Hillmen, Peter; Österborg, Anders

Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004
pp. 86-94(9)
Authors: Dores, Graça M.; Landgren, Ola; McGlynn, Katherine A.; Curtis, Rochelle E.; Linet, Martha S.; Devesa, Susan S.

Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission - long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG)
pp. 95-98(4)
Authors: Schweighofer, Carmen D.; Ritgen, Matthias; Eichhorst, Barbara F.; Busch, Raymonde; Abenhardt, Wolfgang; Kneba, Michael; Hallek, Michael; Wendtner, Clemens-Martin

Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue
pp. 99-106(8)
Authors: Larsen, Ole H.; Clausen, Niels; Persson, Egon; Ezban, Mirella; Ingerslev, Jørgen; Sørensen, Benny

Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches
pp. 107-115(9)
Authors: Ryan, Jacqueline; Quinn, Fiona; Meunier, Armelle; Boublikova, Ludmila; Crampe, Mireille; Tewari, Prerna; O'Marcaigh, Aengus; Stallings, Ray; Neat, Michael; O'Meara, Ann; Breatnach, Fin; McCann, Shaun; Browne, Paul; Smith, Owen; Lawler, Mark

Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome
pp. 116-119(4)
Authors: Crescenzi, Barbara; La Starza, Roberta; Sambani, Constantina; Parcharidou, Agapi; Pierini, Valentina; Nofrini, Valeria; Brandimarte, Lucia; Matteucci, Caterina; Aversa, Franco; Martelli, Massimo Fabrizio; Mecucci, Cristina

A large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene
pp. 120-126(7)
Authors: Beel, Karolien; Cotter, Melanie M.; Blatny, Jan; Bond, Jonathan; Lucas, Geoff; Green, Frances; Vanduppen, Vik; Leung, Daisy W.; Rooney, Sean; Smith, Owen P.; Rosen, Michael K.; Vandenberghe, Peter

A substrate peptide for the FLT3 receptor tyrosine kinase
pp. 127-130(4)
Authors: Böhmer, Frank-D.; Uecker, Andrea

14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia
pp. 131-133(3)
Authors: Deambrogi, Clara; Cresta, Stefania; Cerri, Michaela; Rasi, Silvia; De Paoli, Lorenzo; Ramponi, Antonio; Gaidano, Gianluca; Rossi, Davide

Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy - results from a single UK centre
pp. 133-135(3)
Authors: Motwani, Jayashree; Jesson, Jenny; Sturch, Elaine; Jones, Sue; Eyre, Lisa; Short, Phil; Davies, Paul; Williams, Mike D.; Darbyshire, Phil J.; Hill, Frank G. H.; Lawson, Sarah

Concomitant treatment with lamivudine renders cladribine inactive by inhibition of its phosphorylation
pp. 136-137(2)
Authors: Chtioui, Haithem; Millius, Claudine; Lämmle, Bernhard; Lauterburg, Bernhard H.

MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma
pp. 138-140(3)
Authors: Jung, Inkyung; Aguiar, Ricardo C. T.

CSF3R mutations in paediatric acute myeloid leukaemia
pp. 140-142(3)
Authors: Scharn, N.; Ballmaier, M.; Reinhardt, K.; Ehlers, S.; Zimmermann, M.; Welte, K.; Reinhardt, D.; Germeshausen, M.

Dilemmas in the Diagnosis and Management of Lymphoma
pp. 143-143(1)